Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Volume pickup last 45 mins

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jul 08, 2021 2:02pm

97 Views

Post# 33515465

RE:RE:RE:RE:RE:RE:RE:RE:RE:Volume pickup last 45 mins

stockman75 wrote: It is painful at the moment. Not having any information. No webinars. We just sit and wait. killing me!

SPCEO1 wrote: At some point, a big new discovery in cancer will be enough to offset the failure to market the company well. WEc an't know yet whether TH-1902 will enter into the rarified air where a company's marketing inpetness does't matter anymore because the overwhelmingly important facts surrounding a new drug like TH-1902 (assuming the hopes we currently have actually become reality) is all that is necessary to create a huge wave of interest in the stock. At this point, it really is not something management has much cotrol over.

Will somethign like that happen to TH - probably not. But it is not outof the question either.There is no denying that TH is hunting some seriously big game in cancer right now. And we should have a much better idea about how good of a shot they are before the end of this year.

Bucknelly21 wrote:

SPCEO1 wrote: TH is on the cusp of what could be an amazing medical breakthrough in cancer, so you really don't want anything like that to happen until after we get the cancer data.

Bucknelly21 wrote: I really hope somebody just buys this company I'm just over it

no but I just think they are terrible at the non science part of business, so will they even be able to capitalize on the breakthrough if they get there? Or will they blow that up?

Nice new plan they have